Phosphorescent heteroleptic phenylbenzimidazole dopants
US9212197B2 · kind B2 · utility
1Cited by
34References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2011 |
| Grant date | Dec 15, 2015 |
| Priority date | — |
| Expiry date | Aug 22, 2033 |
Classification
- Technology area (CPC H)Electricity
- CPC primaryH10K2101/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel phosphorescent heteroleptic iridium complexes with benzimidazole and phenylpyridine ligands are provided. These iridium complexes can improve OLED properties, and are useful in white light applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.